Minerva Surgical announced today, the closing of the acquisition of Boston Scientific’s Intrauterine Health franchise. Minerva’s combined product line will provide healthcare practitioners with the most complete and trusted product portfolio for treating Abnormal Uterine Bleeding (AUB). The newly minted suite of minimally invasive tools combines the Minerva Endometrial Ablation System, the fastest growing endometrial ablation product, with the Genesys HTA™ Endometrial Ablation System, trusted for decades by physicians desiring visualization within the uterine cavity during treatment. Also included is Symphion™, the all-in-one tissue removal system that transforms the way physicians remove uterine fibroids, and the Resectr™ device for the removal of endometrial polyps.
Read the full article: Minerva Surgical® Announces Acquisition Closing of Boston Scientific Intrauterine Health Products //
Source: https://www.prnewswire.com/news-releases/minerva-surgical-announces-acquisition-closing-of-boston-scientific-intrauterine-health-products-301057132.html